Conversations in Clinical Trial Readiness podcast

Demystifying Decentralized Clinical Trials with R'Kes Starling

0:00
32:07
Spol 15 sekunder tilbage
Spol 15 sekunder frem

Episode Highlights:

  • The industry and operational challenges facing DCT adoption.
  • How inconsistent nomenclature has contributed to widespread misunderstanding of DCT, and how misnomers have slowed adoption.
  • The challenge of change management and how clarity and infrastructure can be an antidote.
  • How DCT can help boost minority representation in clinical trial research, and why shifting those numbers requires time. 
  • How sponsors can get started with DCT and what they need to consider.
  • Why organizational fit is critical and how to assess it.
  • Why it’s so important to talk with the patients and understand the challenges they face.
  • Why DCT and patient-centric approaches so often go hand-in-hand.
  • How patient engagement is changing, and why clinical trials need to adapt to that.
  • How sites have been forgotten as stakeholders and why they’re still central to clinical development.

Resources:

Flere episoder fra "Conversations in Clinical Trial Readiness"